Evidence map›Paper›PMID 35043507›Full record

Trial reportWound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society2022

Topically administered purified clinoptilolite-tuff for the treatment of cutaneous wounds: A prospective, randomised phase I clinical trial.

Julia Deinsberger, Elias Marquart, Stephane Nizet, Claudia Meisslitzer, Cornelius Tschegg, Kateryna Uspenska, Ghazaleh Gouya, Jan Niederdöckl, Michael Freissmuth, Michael Wolzt and 1 more

Open access · hybridAbstract readClinical Trial, Phase IRandomized Controlled Trial
In one paragraph

Trial report in Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Topically administered purified clinoptilolite-tuff for the treatment of cutaneous wounds: A prospective, randomised phase I clinical trial.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society · 2022
    Trial
  3. Article
  4. Review
  5. Review
  6. Effects of Myroxylon pereirae, Phenytoin, and Clinoptilolite After Pharyngocutaneous Fistula: An Experimental Animal Model.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2025
    Article
  7. PMA-Zeolite: Chemistry and Diverse Medical Applications.Journal of functional biomaterials · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Julia DeinsbergerDepartment of Dermatology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0002-4237-1526
Elias MarquartDepartment of Dermatology, Medical University of Vienna, Vienna, Austria.
Stephane NizetGlock Health, Science and Research GmbH, Deutsch-Wagram, Austria.
Claudia MeisslitzerGlock Health, Science and Research GmbH, Deutsch-Wagram, Austria.
Cornelius TscheggGlock Health, Science and Research GmbH, Deutsch-Wagram, Austria.
Kateryna UspenskaGouya-Insights, Vienna, Austria.
Ghazaleh GouyaGouya-Insights, Vienna, Austria.
Jan NiederdöcklDepartment of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Michael FreissmuthCenter for Physiology and Pharmacology, Institute of Pharmacology, Gaston H. Glock Laboratories for Exploratory Drug Research, Medical University of Vienna, Vienna, Austria.
Michael WolztDepartment of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Benedikt WeberDepartment of Dermatology, Medical University of Vienna, Vienna, Austria.
Medical University of Vienna · ATDeutsche Telekom (Austria) · ATClinical Insights · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In an ageing society, chronic ulcers pose an increasingly relevant healthcare issue associated with significant morbidity and an increasing financial burden. Hence, there is an unmet medical need for novel, cost-effective therapies that improve healing of chronic cutaneous wounds. This prospective, randomised, open-label, phase I trial investigated the safety and tolerability of topically administered purified clinoptilolite-tuff (PCT), mainly consisting of the naturally occurring zeolite-mineral clinoptilolite, in artificial wounds in healthy male volunteers compared to the standard of care (SoC). We found that topically administered PCT was safe for therapeutic application in acute wounds in healthy male volunteers. No significant differences in wound healing or wound conditions were observed compared to SoC-treated wounds. However, we found a significantly higher proportion of CD68-positive cells and a significantly lower proportion of α-smooth muscle actin-positive cells in PCT-treated wounds. Scanning electron microscopy revealed PCT particles in the restored dermis in some cases. However, these did not impede wound healing or clinical symptoms. Hence, purified PCT could represent an attractive, cost-effective wound treatment promoting the process of healing.

Indexed as

Soft Tissue InjuriesZeolitesHumansMaleProspective StudiesWound HealingclinoptiloliteZeoliteschronic woundsclinical trialclinoptilolitewound dressing zeolite

Identifiers

PMID35043507
PMCPMC9306511
OpenAlexW4206787829

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.